Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome
Condition: Endogenous Cushing's Syndrome Intervention: Drug: Osilodrostat Sponsor: RECORDATI GROUP Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 19, 2022 Category: Research Source Type: clinical trials
SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome
Conditions: Cushing's Syndrome I; Cushing Disease Due to Increased ACTH Secretion; Cortisol Excess; Cortisol; Hypersecretion; Cortisol Overproduction; Ectopic ACTH Secretion Interventions: Drug: SPI-62; Drug: Placebo Sponsor: Sparrow Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2022 Category: Research Source Type: clinical trials